Ticagrelor: The first approved reversible oral antiplatelet agent

Platelet aggregation plays an important role in the pathophysiology of acute coronary syndrome (ACS). Aspirin is the most widely used antiplatelet agent and acts by inhibiting thromboxane A(2)-induced platelet activation. But it does not prevent platelets activation and aggregation by other signalin...

Descripción completa

Detalles Bibliográficos
Autor principal: Goel, Divya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678676/
https://www.ncbi.nlm.nih.gov/pubmed/23776835
http://dx.doi.org/10.4103/2229-516X.112234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678676/
https://www.ncbi.nlm.nih.gov/pubmed/23776835
http://dx.doi.org/10.4103/2229-516X.112234

Ejemplares similares